Avatar
Accepting New Patients

Raffi Tachdjian, MD

  • Pediatric Allergy and Immunology

Languages

English, French

Education

Medical Board Certification

Allergy and Immunology, American Board of Allergy and Immunology, 2009

Fellowship

Allergy & Immunology, UCLA School of Medicine, 2007

Residency

Pediatrics, Harvard Medical School/Massachusetts General Hospital, 2004

Internship

Pediatrics, Harvard Medical School/Massachusetts General Hospital, 2002

Degrees

MD, Morehouse School of Medicine, 2001
MPH, University of Alabama at Birmingham, 1994

Recognitions

  • Super Doctors® Southern California, 2024
  • Top Doctors, Los Angeles Magazine, 2021

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

UCLA Mattel Children's Hospital

Medical Services

Research

Interests

  • Asthma
  • Eosinophilic Esophagitis
  • Hereditary Angioedema
  • Atopic Dermatitis
  • Chronic Urticaria
  • Chronic Rhinosinusitis with Nasal Polyposis
  • Chronic Granulomatous Disease
  • WHIM
  • Allergic Rhinitis
  • Pain and Inflammation

Publications

  1. Riedl MA, Tachdjian R, Lumry WR, et al.N Engl J Med. 2024 Jul 4;391(1):21-31. Efficacy and Safety of Donidalorsen for Hereditary Angioedema.

  2. Riedl MA, et al. N Engl J Med. 2024 Jul 4;391(1):32-43. Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.

  3.  Staubach P, Tachdjian R, Li HH, Hakl R, Aygören-Pürsün E, Wieman L, Lawo JP, Craig TJ.Clin Exp Allergy. 2024 Dec;54(12):1020-1023. Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks.
  4.  Anderson J, Soteres D, Tachdjian R, Mellor J, Earl L, Connolly H, Wynne-Cattanach K, Moran K, Sing K, Schultz BG, Juethner S.Allergy Asthma Proc. 2024 Nov 1;45(6):426-433. Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis.
  5.  Petersen RS, Bordone L, Riedl MA, Tachdjian R, Craig TJ, Lumry WR, Manning ME, Bernstein JA, Raasch J, Zuraw BL, Deng Y, Newman KB, Alexander VJ, Lui C, Schneider E, Cohn DM.Allergy. 2024 Mar;79(3):724-734. A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema.
  6.  Tachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK.Allergy Asthma Proc. 2024 Jan 22;45(1):37-43. Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks.
  7. Tachdjian R. Pain Ther. 2013 Dec;2(2):129-34. Complex regional pain syndrome treated with intravenous immunoglobulin in a patient with common variable immune deficiency.

  8. Young G, Tachdjian R, Baumann K, Panopoulos G.Comprehensive management of chronic pain in haemophilia. Haemophilia. 2014 Mar;20(2):e113-20.

  9. Kuhlen J, Guyer A, Morphew T, Tachdjian R, Banerji A. Assessment of home infusion program for treating nonlaryngeal hereditary angioedema attacks. Ann Allergy Asthma Immunol. 2014 May;112(5):471-2
  10. MacGinnitie AJ, Davis-Lorton M, Stolz LE, Tachdjian R. Use of ecallantide in pediatric hereditary angioedema. Pediatrics. 2013 Aug;132(2):e490-7

Additional publications can be found on PubMed.gov >

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • Medicare Advantage
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

Recognitions

  • Super Doctors® Southern California, 2024
  • Top Doctors, Los Angeles Magazine, 2021